Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants

ClinicalTrials.gov ID: NCT00006401

Public ClinicalTrials.gov record NCT00006401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 12:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Inhaled NO for the Prevention of Chronic Lung Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine whether or not inhaled nitric oxide (iNO) safely decreases the incidence of chronic lung disease (CLD) in premature infants.

Study identification

NCT ID
NCT00006401
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
793 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
Up to 1 Year
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2000
Primary completion
Aug 31, 2005
Completion
Sep 30, 2007
Last update posted
Oct 5, 2015

2000 – 2007

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
St. Joseph's Hospital Phoenix Arizona 85013
Loma Linda University Medical Center Loma Linda California 92350
Univeristy of Southern California/Good Samaritan Hospital Los Angeles California 90033
Children's Hospital Denver Colorado 80218-1088
University of Connecticut Health Center Farmington Connecticut 06030
University of Iowa Hospital & Clinics Iowa City Iowa 52242
University of North Carolina Chapel Hill Chapel Hill North Carolina 27599
Duke University Medical Center Durham North Carolina 27710
Children's Hospital of Oklahoma Oklahoma City Oklahoma 73104
Pennsylvania Hospital Philadelphia Pennsylvania 19107
Magee-Women's Hospital Pittsburgh Pennsylvania 15213
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Medical Center Nashville Tennessee 37232
Utah Valley Regional Medical Center Provo Utah 84604

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2015 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006401 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →